Lauren B. Krupp, M.D.
Professor, Clinical Neurology
- American Board of Psychiatry and Neurology
Medical School: Albert Einstein College of Medicine - New York, NY
Residency in Neurology: Albert Einstein College of Medicine - New York, NY
Fellowship in Neuroimmunology: National Institutes of Health - Bethesda, MD
- Clinical Trials
- CNS Demyelination
- Multiple Sclerosis
- Neuromyelitis Optica (Devic's Disease)
- Optic Neuritis
- Pediatric Multiple Sclerosis and related disorders
- Transverse Myelitis, Acute Disseminated Encephalomyelitis
Dr. Lauren Krupp received her medical degree from the Albert Einstein College of Medicine, completed her Neurology Residency at Albert Einstein and Montefiore Medical Center, and then completed additional fellowship training at Neuroimmunology/Multiple Sclerosis Branch of the National Institutes of Health. She a Fellow of the American Academy of Neurology.
She is currently a Professor of Neurology and Psychology at the State University of New York at Stony Brook and Medical Center and specializes in Multiple Sclerosis. She is the Director of the Pediatric MS Center at Stony Brook (the first and only Pediatric MS Center in the United States), co-directs the adult MS Center at Stony Brook, and directs a research program that covers the relations between fatigue, mood disturbance, and cognitive dysfunction in MS within the department of Neurology.
Other projects include studies of children and adolescents with MS, evaluation and treatment of MS associated cognitive problems and fatigue. She has received for her research grant support form the National Multiple Sclerosis Society, the National Institutes of Disability and Rehabilitation Research, private foundations, and grants from pharmaceutical companies. She has published over 100 original articles or chapters in books and is an internationally acknowledged authority in multiple sclerosis.
Led by Lauren Krupp, MD, a team of neurology and pathology researchers have discovered a group of 12 proteins associated with pediatric multiple sclerosis (MS). This finding could lead to a new panel of diagnostic and prognostic markers in pediatric MS. Their study is reported in the April 2009 issue of the journal Multiple Sclerosis.